Crystal Mackall

Founding Director, Stanford Center for Cancer Cell Therapy · Stanford Health Care

Credentials: · ·

History

Stanford Center for Cancer Cell Therapy · Stanford Health Care
Present
Parker Institute for Cancer Immunotherapy at Stanford Center · Stanford Health Care
Present
Stanford Medicine Center for Cancer Cell Therapy · Stanford Health Care
Present

Next Generation Immunotherapies for Pediatric Cancers
National Cancer Institute · R35
Contact PI · $2.8M · Stanford University
2024–2031
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
National Cancer Institute · P01
Project lead · $2M · Stanford University
1997–2030
Next Generation GPC2-CARs for Medulloblastoma
National Cancer Institute · UH3
Contact PI · $2.2M · Stanford University
2024–2029
Attacking the Immunopeptidome of Ewing Sarcoma
National Cancer Institute · U01
Contact PI · $2.5M · Stanford University
2023–2028

Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies
Principal investigator · Active not recruiting · Phase 1
Stanford University
2017–2035
Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas
Principal investigator · Completed · Phase 1, Phase 2
National Cancer Institute (NCI)
2015–2023
HGS-ETR2 to Treat Children With Solid Tumors
Principal investigator · Terminated · Phase 1
National Cancer Institute (NCI)
2006–2015
Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma
Principal investigator · Completed
National Cancer Institute (NCI)
2004–2015